It is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, which may lead to enhanced weight loss and metabolic effects compared to single or dual agonists
PMID:7342494
GLP-1 Injection Timing: Morning or Night Administration Guide GLP-1 receptor agonists are injectable medications used for type 2 diabetes management and weight control in adults with obesity
Turnock L, Hearne E, Germain J, et al
The experiments revealed that gastric secretion was stimulated by the consumption of mixed meals, meats and milk, but was inhibited by fatty food and possibly aided by an adaptive immune response (Ivy, Lim, McCarthy
Most users report increased energy in 710 days and visible fat-loss changes in 34 weeks, especially when combined with diet and training.